U.S. Physical Therapy, Inc. USPH
$83.08
-$0.31-0.37%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 668.89M | 654.41M | 642.78M | 623.05M | 598.53M |
| Total Other Revenue | 135.39M | 133.28M | 130.56M | 127.90M | 123.68M |
| Total Revenue | 804.28M | 787.69M | 773.34M | 750.95M | 722.20M |
| Cost of Revenue | 631.62M | 615.17M | 602.32M | 586.04M | 562.90M |
| Gross Profit | 172.65M | 172.52M | 171.02M | 164.91M | 159.30M |
| SG&A Expenses | 72.18M | 70.95M | 68.92M | 66.37M | 63.34M |
| Depreciation & Amortization | 21.06M | 21.18M | 21.06M | 22.30M | 20.97M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 724.86M | 707.30M | 692.30M | 674.71M | 647.21M |
| Operating Income | 79.42M | 80.39M | 81.04M | 76.23M | 75.00M |
| Income Before Tax | 67.45M | 71.05M | 77.81M | 81.18M | 70.64M |
| Income Tax Expenses | 17.58M | 18.36M | 19.81M | 19.85M | 17.18M |
| Earnings from Continuing Operations | 49.87 | 52.69 | 58.01 | 61.32 | 53.46 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -17.64M | -17.97M | -18.42M | -16.65M | -15.30M |
| Net Income | 32.23M | 34.72M | 39.58M | 44.67M | 38.16M |
| EBIT | 79.42M | 80.39M | 81.04M | 76.23M | 75.00M |
| EBITDA | 101.82M | 102.91M | 103.43M | 99.68M | 96.99M |
| EPS Basic | 0.18 | 0.50 | 1.42 | 2.38 | 2.29 |
| Normalized Basic EPS | 1.74 | 1.78 | 1.76 | 1.70 | 1.83 |
| EPS Diluted | 0.18 | 0.50 | 1.42 | 2.38 | 2.29 |
| Normalized Diluted EPS | 1.74 | 1.78 | 1.76 | 1.70 | 1.83 |
| Average Basic Shares Outstanding | 60.61M | 60.74M | 60.70M | 60.62M | 60.50M |
| Average Diluted Shares Outstanding | 60.61M | 60.74M | 60.70M | 60.62M | 60.50M |
| Dividend Per Share | 1.82 | 1.81 | 1.80 | 1.79 | 1.78 |
| Payout Ratio | 85.50% | 78.80% | 69.13% | 60.80% | 70.63% |